U.S. FDA Approves Delgocitinib Cream (Anzupgo, LEO Pharma) for Chronic Hand Eczema: What to Know
The U.S. Food and Drug Administration (FDA) has approved delgocitinib cream (Anzupgo, LEO Pharma) for the topical treatment of moderate-to-severe chronic hand eczema (CHE) in adults who have had an inadequate response to, or for whom topical corticosteroids are not advisable. “In my career as a dermatologist, I have witnessed firsthand the significant burden that […]